Ablation or inhibition of SHP2 in macrophages reduced the production of pro‐inflammatory cytokines and prevented the development of psoriasis‐like skin inflammation in both the IMQ‐induced murine model and psoriatic patients. This evidence concerns the gene PTPN11 and psoriasis.